| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.1 | 0.4 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |